Literature DB >> 7671932

Fungal endocarditis.

E Rubinstein1, R Lang.   

Abstract

Fungal endocarditis has become an important infection associated with medical progress and a modern lifestyle. The most common organisms isolated from patients with fungal endocarditis are: Aspergillus spp.; Candida spp. and Torulopsis glabrata. Men are more frequently affected than women and predisposing factors include: previous cardiac surgery, antibiotic use and hyperalimentation, long-term i.v. catheters. Common clinical findings in patients with endocarditis include: fever, changing murmurs, peripheral emboli which are characteristically large and chorioretinitis. Characteristic laboratory findings are absent and positive blood cultures are obtained only in a relatively small number of patients. Characteristically, Aspergillus spp. almost never grow in blood cultures and must be isolated from removed emboli, from the diseased valve or from infected foreign bodies. Overall survival in patients with fungal endocarditis is rather poor, and hardly exceeds 50%. In general, a combined surgical-medical approach would yield the best results. New therapeutic modalities are needed in order to improve the prognosis of fungal endocarditis.

Entities:  

Mesh:

Year:  1995        PMID: 7671932     DOI: 10.1093/eurheartj/16.suppl_b.84

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  21 in total

1.  Disseminated Sporothrix brasiliensis infection with endocardial and ocular involvement in an HIV-infected patient.

Authors:  Mario León Silva-Vergara; Zoilo Pires de Camargo; Patricia Ferreira Silva; Michel Reis Abdalla; Ricardo Nilsson Sgarbieri; Anderson Messias Rodrigues; Keila Cristina dos Santos; Cristina Hueb Barata; Kennio Ferreira-Paim
Journal:  Am J Trop Med Hyg       Date:  2012-03       Impact factor: 2.345

Review 2.  Aspergillus fumigatus pacemaker lead endocarditis: a case report and review of the literature.

Authors:  R Leong; Brian R Gannon; Tim J Childs; Phillip A Isotalo; Hoshiar Abdollah
Journal:  Can J Cardiol       Date:  2006-03-15       Impact factor: 5.223

3.  Comparison of voriconazole (UK-109,496) and itraconazole in prevention and treatment of Aspergillus fumigatus endocarditis in guinea pigs.

Authors:  M V Martin; J Yates; C A Hitchcock
Journal:  Antimicrob Agents Chemother       Date:  1997-01       Impact factor: 5.191

Review 4.  Aspergillus endocarditis, myocarditis and pericarditis complicating necrotizing fasciitis. Case report and subject review.

Authors:  C Sergi; J Weitz; W J Hofmann; P Sinn; A Eckart; G Otto; P A Schnabel; H F Otto
Journal:  Virchows Arch       Date:  1996-10       Impact factor: 4.064

5.  Contemporary comparison of infective endocarditis caused by Candida albicans and Candida parapsilosis: a cohort study.

Authors:  Adrián Jerónimo; Carmen Olmos; Isidre Vilacosta; Carmen Sáez; Javier López; Marta Sanz; Gonzalo Cabezón; Javier B Pérez-Serrano; Pablo Zulet; J Alberto San Román
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2022-05-14       Impact factor: 3.267

6.  Candida endocarditis with mycotic pulmonary emboli following re-do Rastelli operation.

Authors:  N T Wijesekera; M N Sheppard; M J Mullen
Journal:  Heart       Date:  2004-06       Impact factor: 5.994

Review 7.  Candida parapsilosis endocarditis: a comparative review of the literature.

Authors:  C Garzoni; V A Nobre; J Garbino
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-12       Impact factor: 3.267

Review 8.  Recognition, management and prophylaxis of endocarditis.

Authors:  D Stamboulian; E Carbone
Journal:  Drugs       Date:  1997-11       Impact factor: 9.546

9.  Fungal Endocarditis.

Authors:  Eyal Nadir; Ethan Rubinstein
Journal:  Curr Infect Dis Rep       Date:  2004-08       Impact factor: 3.725

10.  Atypical early Aspergillus endocarditis post prosthetic mitral valve repair: a case report.

Authors:  Ahmed AbdulAziz Abuzaid; Mahmood Zaki; Habib Tarif
Journal:  Heart Views       Date:  2015 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.